(INNS)
VOBRAMITAMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD276 (B7H3, B7-H3, B7-RELATED PROTEIN 2, B7RP2, B7RP-2, B7 HOMOLOG 3, B7 HOMOLOGUE 3)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-447) [VH (HOMO SAPIENS IGHV3-7*01 (89.8%) -(IGHD) -IGHJ6*01 (92.9%), CDR-IMGT [8.8.10] (26-33.51-58.97-106)) (1- 117) -HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1 (CH1 R120 (214) (118-215), HINGE 1-15 (216-230), CH2 (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-447)) (118-447)], (220-215')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-215') [V-KAPPA (HOMO SAPIENS IGKV1-39*01 (86.3%) -IGKJ5*01 (100%), CDR-IMGT [6.3.10] (27-32.50-52.89-98)) (1'-108') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154), V101 (192) (109'- 215')]; DIMER (226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA(WHO)
VOBRAMITAMABUM(INN)